Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Chimeric Antigen Receptor T-cell Therapy
51%
Non-relapse Mortality
44%
Acute Myeloid Leukemia
42%
Chimeric Antigen Receptor T Cells (CAR-T)
39%
Acute Leukemia
32%
Marrow Transplantation
29%
Overall Survival
27%
Leukemia Patients
26%
European Society
24%
Anti-CD19 chimeric Antigen Receptor T Cells
19%
Transplantation
19%
Large B-cell Lymphoma
19%
Graft-versus-host Disease (GvHD)
18%
Hematopoietic Stem Cell Transplantation
17%
Hazard Ratio
16%
Fludarabine
15%
Confidence Interval
14%
Progression-free Survival
14%
Relapsed or Refractory
14%
Comorbidity
13%
Conditioning Regimen
13%
Machine Learning
12%
Cytokine Release Syndrome
11%
Mortality Prediction
11%
Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)
11%
Machine Learning Algorithms
10%
Acute Lymphoblastic Leukemia
10%
Working Party
10%
Umbilical Cord Blood Transplantation
10%
Point-of-care
10%
Aggressive B-cell Lymphoma
10%
Leukemia-free Survival
9%
CD19 chimeric Antigen Receptor T Cells
9%
High Risk
9%
Hematopoietic Cell Transplantation
9%
Lactate Dehydrogenase
9%
FMS-like Tyrosine Kinase 3 (FLT3)
9%
Microbiome
9%
Risk Factors
9%
Conditioning Intensity
9%
Transplantation Conditioning
8%
External Validation
8%
Acute Coronary Syndrome
8%
Reduced-intensity Conditioning
8%
Survival Prediction
8%
Tisagenlecleucel
8%
Artificial Intelligence
7%
Unrelated Donor
7%
Busulfan
7%
Medicine and Dentistry
Chimeric Antigen Receptor T-Cell Immunotherapy
48%
Chimeric Antigen Receptor T-Cell
39%
Acute Myeloid Leukemia
38%
Allogeneic Hematopoietic Stem Cell Transplantation
32%
Overall Survival
28%
Disease
28%
Conditioning
22%
Acute Leukemia
22%
Large-Cell Lymphoma
20%
Transplantation
19%
Hazard Ratio
17%
Cell Transplantation
17%
Hematopoietic Stem Cell
17%
Allogeneic Stem Cell Transplantation
17%
Progression Free Survival
14%
Hematopoietic Stem Cell Transplantation
13%
Cytokine Release Syndrome
12%
Toxicity and Intoxication
12%
Acute Lymphoblastic Leukemia
12%
Neoplasm
12%
Effector Cell
12%
Leukemia
10%
Lactate Dehydrogenase
10%
Cord Blood
10%
B-Cell Lymphoma
10%
Risk Stratification
9%
Diffuse Large B-Cell Lymphoma
8%
Fludarabine
8%
Prognosis
8%
Hematologic Malignancy
8%
Biological Marker
8%
Axicabtagene Ciloleucel
7%
Scoring System
7%
Cardiovascular System
7%
Adverse Event
7%
Stem Cell Therapy
7%
Odds Ratio
6%
Cord Blood Stem Cell Transplantation
6%
Survival Prediction
6%
Hematology
6%
Kidney Function
6%
Cell Therapy
6%
Neurotoxicity
6%
Systematic Review
6%
Meta-Analysis
6%
Infusion
6%
Cumulative Incidence
6%
Multiple Myeloma
6%
FMS-Like Tyrosine Kinase 3
6%
Tumor Progression
5%
Immunology and Microbiology
Myeloid
38%
Cell Transplantation
32%
Hematopoietic Cell
32%
Conditioning
29%
Allogeneic Hematopoietic Stem Cell Transplantation
28%
Overall Survival
28%
Chimeric Antigen Receptor T-Cell Therapy
23%
Comorbidity
22%
Allogeneic Stem Cell Transplantation
22%
Transplant Procedure
21%
B Cell
19%
Chimeric Antigen Receptor T-Cell
18%
CD19
16%
Graft-Versus-Host Disease
14%
Hematopoietic Stem Cell Transplantation
14%
Effector Cell
12%
Acute Graft Versus Host Disease
11%
Microflora
11%
Stem Cell Transplantation
11%
Microbiome
8%
Cytokine Release Syndrome
8%
Immunotherapy
7%
T Cell
7%
Data Mining
7%
Umbilical Cord Blood
6%
Survival Prediction
6%
Cord Blood Stem Cell Transplantation
6%
Feces microflora
6%
Allotransplantation
6%
Kidney Function
6%
Cytotoxicity
6%
Methotrexate
5%
Multiple Myeloma
5%
Chronic Graft Versus Host Disease
5%
Glomerulus Filtration
5%
